Vident Advisory’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $732K | Buy |
8,381
+626
| +8% | +$54.6K | 0.01% | 867 |
|
|
2025
Q1 | $530K | Buy |
7,755
+2,538
| +49% | +$173K | 0.01% | 1004 |
|
|
2024
Q4 | $406K | Sell |
5,217
-25,324
| -83% | -$1.97M | 0.01% | 1051 |
|
|
2024
Q3 | $2.05M | Buy |
30,541
+25,040
| +455% | +$1.68M | 0.05% | 380 |
|
|
2024
Q2 | $624K | Buy |
5,501
+450
| +9% | +$51K | 0.02% | 787 |
|
|
2024
Q1 | $701K | Buy |
5,051
+363
| +8% | +$50.4K | 0.01% | 687 |
|
|
2023
Q4 | $582K | Sell |
4,688
-156
| -3% | -$19.4K | 0.01% | 720 |
|
|
2023
Q3 | $452K | Buy |
+4,844
| New | +$452K | 0.01% | 736 |
|